195 related articles for article (PubMed ID: 37400666)
21. Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.
Green AL; Ramkissoon SH; McCauley D; Jones K; Perry JA; Hsu JH; Ramkissoon LA; Maire CL; Hubbell-Engler B; Knoff DS; Shacham S; Ligon KL; Kung AL
Neuro Oncol; 2015 May; 17(5):697-707. PubMed ID: 25366336
[TBL] [Abstract][Full Text] [Related]
22. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
[TBL] [Abstract][Full Text] [Related]
23. Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.
Kerstetter-Fogle AE; Harris PLR; Brady-Kalnay SM; Sloan AE
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698368
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
26. Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma.
Finotto L; Cole B; Giese W; Baumann E; Claeys A; Vanmechelen M; Decraene B; Derweduwe M; Dubroja Lakic N; Shankar G; Nagathihalli Kantharaju M; Albrecht JP; Geudens I; Stanchi F; Ligon KL; Boeckx B; Lambrechts D; Harrington K; Van Den Bosch L; De Vleeschouwer S; De Smet F; Gerhardt H
EMBO Mol Med; 2023 Nov; 15(11):e18144. PubMed ID: 37791581
[TBL] [Abstract][Full Text] [Related]
27. EGFR gene overexpression retained in an invasive xenograft model by solid orthotopic transplantation of human glioblastoma multiforme into nude mice.
Yi D; Hua TX; Lin HY
Cancer Invest; 2011 Mar; 29(3):229-39. PubMed ID: 21314332
[TBL] [Abstract][Full Text] [Related]
28. Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.
Welker AM; Jaros BD; Puduvalli VK; Imitola J; Kaur B; Beattie CE
Dis Model Mech; 2016 Feb; 9(2):199-210. PubMed ID: 26659251
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract][Full Text] [Related]
30. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents.
Li X; Li M
Med Res Rev; 2023 Jan; 43(1):212-236. PubMed ID: 36029178
[TBL] [Abstract][Full Text] [Related]
31. The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies.
Luís Â; Marcelino H; Rosa C; Domingues F; Pereira L; Cascalheira JF
Eur J Pharmacol; 2020 Jun; 876():173055. PubMed ID: 32145324
[TBL] [Abstract][Full Text] [Related]
32. The Zebrafish Xenograft Platform: Evolution of a Novel Cancer Model and Preclinical Screening Tool.
Wertman J; Veinotte CJ; Dellaire G; Berman JN
Adv Exp Med Biol; 2016; 916():289-314. PubMed ID: 27165359
[TBL] [Abstract][Full Text] [Related]
33. A novel zebrafish xenotransplantation model for study of glioma stem cell invasion.
Yang XJ; Cui W; Gu A; Xu C; Yu SC; Li TT; Cui YH; Zhang X; Bian XW
PLoS One; 2013; 8(4):e61801. PubMed ID: 23613942
[TBL] [Abstract][Full Text] [Related]
34. Propofol enhances the sensitivity of glioblastoma cells to temozolomide by inhibiting macrophage activation in tumor microenvironment to down-regulate HIF-1α expression.
Zhao W; Yun K
Exp Cell Res; 2022 Sep; 418(2):113277. PubMed ID: 35810776
[TBL] [Abstract][Full Text] [Related]
35. Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma.
Welker AM; Jaros BD; An M; Beattie CE
Neuroscience; 2017 Jul; 356():35-43. PubMed ID: 28526577
[TBL] [Abstract][Full Text] [Related]
36. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
[TBL] [Abstract][Full Text] [Related]
37. Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.
Singh MM; Johnson B; Venkatarayan A; Flores ER; Zhang J; Su X; Barton M; Lang F; Chandra J
Neuro Oncol; 2015 Nov; 17(11):1463-73. PubMed ID: 25795306
[TBL] [Abstract][Full Text] [Related]
38. BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models.
Hao X; Bahia RK; Cseh O; Bozek DA; Blake S; Rinnenthal J; Weyer-Czernilofsky U; Rudolph D; Artee Luchman H
Neuro Oncol; 2023 May; 25(5):913-926. PubMed ID: 36521007
[TBL] [Abstract][Full Text] [Related]
39. Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient.
Larsson S; Wenger A; Dósa S; Sabel M; Kling T; Carén H
Carcinogenesis; 2018 Oct; 39(10):1304-1309. PubMed ID: 29982329
[TBL] [Abstract][Full Text] [Related]
40. Vitamin C deficient reduces proliferation in a human periventricular tumor stem cell-derived glioblastoma model.
Jara N; Ramirez E; Ferrada L; Salazar K; Espinoza F; González-Chavarría I; Nualart F
J Cell Physiol; 2021 Aug; 236(8):5801-5817. PubMed ID: 33432597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]